DBT (also known as 3D mammography) is a widely popular imaging technique. It offers clear breast imaging through volumetric reconstruction of the breast from a countable number of low-dose two-dimensional projections obtained with the help of an X-ray tube. DBT offers superior benefits over the other existing imaging modalities, as it early detects cancer more precisely in the dense breast tissues.

The global Digital Breast Tomosynthesis market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Digital Breast Tomosynthesis volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Digital Breast Tomosynthesis market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Digital Breast Tomosynthesis Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Stand-alone DBT equipment
Integrated

Segment by Application
Diagnostic Centers
Hospitals
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Siemens
Philips
Hologic
GE Healthcare
Canon Medical Systems
Perlong Medical
ANKE
Angell
Sinomdt
Macroo
Orich Medical Equipment
Planmed
Metaltronica
MEDI-FUTURE
FUJIFILM
IMS
Genoray